| Literature DB >> 30479480 |
S Sotiriou1, N Koletsas2, T Koletsa1, S Touloupidis3, M Lambropoulou4.
Abstract
BACKGROUND: Thyroid transcription factor-1 (TTF-1) has been considered a sensitive marker for thyroid and lung tumors. Recent data have shown that a wide range of neoplasms may express TTF-1. CASE SERIES: We performed an immunohistochemical study in a case series of 42 urothelial carcinomas (UCs) on tissue microarrays sections, in order to investigate how often UCs express the TTF-1 protein and the diagnostic utility of this marker. In addition, we sought to determine by immunohistochemistry if there is an association between TTF-1 expression and the expression of specific basal-like or luminal markers. Five out of the 42 cases (11.9 %) were positive for TTF-1. Three positive tumors concerned non-invasive papillary UCs. There was no association between TTF-1 expression and tumor grade (χ2, p =0.419), stage (χ2, p =0.550) or cytokeratin 5/6 (χ2, p =0.330), cytokeratin 20 (χ2, p =0.995) and estrogen receptors expression (χ2, p =0.268).Entities:
Keywords: Thyroid transcription factor-1; cytokeratin 20; cytokeratin 5/6; estrogen receptors; immunohistochemistry; metastatic lung tumor; urothelial neoplasm
Year: 2017 PMID: 30479480 PMCID: PMC6248004
Source DB: PubMed Journal: Hippokratia ISSN: 1108-4189 Impact factor: 0.471